Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary biliary cirrhosis: the future.

Marlyn J Mayo1

  • 1Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Room F.4.120, Dallas, TX 75390, USA. marlyn.mayo@utsouthwestern.edu

Clinics in Liver Disease
|November 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seladelpar Improved Itch, Itch-Related Sleep Disturbance and Measures of Fatigue in Patients With Primary Biliary Cholangitis and Pruritus in the Phase 3 RESPONSE Trial.

Alimentary pharmacology & therapeutics·2026
Same author

Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary Cholangitis.

The American journal of gastroenterology·2026
Same author

The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view.

Nature reviews. Gastroenterology & hepatology·2026
Same author

Comment on Ejaz et al. Letter to the Editor.

Liver international : official journal of the International Association for the Study of the Liver·2025
Same author

Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.

The lancet. Gastroenterology & hepatology·2025
Same author

Assessment of PBC Pruritus From the ITCH-E Study: Quality of Life, Productivity, and Treatment Experiences.

Liver international : official journal of the International Association for the Study of the Liver·2025
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Understanding primary biliary cholangitis (PBC) pathogenesis is crucial. Advances in molecular technology and in vitro models using human biliary cells are poised to overcome past research limitations.

Area of Science:

  • Hepatology
  • Immunology
  • Cell Biology

Background:

  • Primary biliary cholangitis (PBC) pathogenesis remains incompletely understood.
  • Research is hindered by the lack of adequate animal models for PBC.
  • Key questions regarding PBC etiology persist.

Purpose of the Study:

  • To highlight the critical need for understanding PBC pathogenesis.
  • To discuss the impact of technological advancements on PBC research.
  • To emphasize the potential for future breakthroughs in PBC investigation.

Main Methods:

  • Review of current limitations in PBC research.
  • Discussion of emerging molecular technologies.
  • Highlighting the utility of in vitro studies with human biliary epithelial cells.

Related Experiment Videos

Main Results:

  • The study identifies critical knowledge gaps in PBC pathogenesis.
  • It acknowledges the significant limitations imposed by the lack of suitable animal models.
  • It points to the rapid advancement of molecular technologies as a promising avenue.

Conclusions:

  • Despite challenges, advancements in molecular tools and cell culture techniques are enabling new approaches to study PBC.
  • Investigators are now better equipped to address fundamental questions about PBC pathogenesis.
  • Future research holds significant promise for advancing the understanding and treatment of PBC.